Literature DB >> 3257931

Inhibitory effects of prostaglandin E1 on T-cell mediated cytotoxicity against isolated mouse liver cells.

M Ogawa1, T Mori, Y Mori, S Ueda, H Yoshida, I Kato, K Iesato, Y Wakashin, M Wakashin, K Okuda.   

Abstract

The effects of prostaglandin E1 on cell-mediated cytotoxicity against hepatocytes were investigated using an in vitro cytotoxic assay system. Isolated liver cells from normal C57BL/6 mice were used as the target cells, and effector cells were obtained from spleens of C57BL/6 mice in which experimental hepatitis had been induced by immunization with syngeneic liver antigens. In this assay system, spleen T cells adhering to nylon wool demonstrated a high cytotoxic activity against target liver cells. The cytotoxicity was markedly reduced by prostaglandin E1 at concentrations greater than 10(-7) M. Maximum suppressive activity was obtained when prostaglandin E1 was continuously present during the assay period. By contrast, indomethacin, a specific inhibitor of prostaglandin synthesis, enhanced the cytotoxic activity of effector cells. These data seem to indicate that exogenously added prostaglandin E1 has an inhibitory effect on cell-mediated cytotoxicity of effector spleen cells against target hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257931     DOI: 10.1016/0016-5085(88)90562-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Protective effects of prostaglandin E1 on hepatocytes.

Authors:  Xian-Ling Liu; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Indomethacin up-regulates the generation of lymphokine-activated killer-cell activity and antibody-dependent cellular cytotoxicity mediated by interleukin-2.

Authors:  A Eisenthal
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 3.  Fulminant hepatitis.

Authors:  S Sinclair; A Wakefield; G Levy
Journal:  Springer Semin Immunopathol       Date:  1990

4.  Prostacyclin inhibition by indomethacin aggravates hepatic damage and encephalopathy in rats with thioacetamide-induced fulminant hepatic failure.

Authors:  Chi-Jen Chu; Ching-Chin Hsiao; Teh-Fang Wang; Cho-Yu Chan; Fa-Yauh Lee; Full-Young Chang; Yi-Chou Chen; Hui-Chun Huang; Sun-Sang Wang; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

5.  Eleven cases of postoperative hepatic infarction following pancreato-biliary surgery.

Authors:  Fumihiko Miura; Takehide Asano; Hodaka Amano; Masahiro Yoshida; Naoyuki Toyota; Keita Wada; Kenichoro Kato; Koichi Hayano; Susumu Kadowaki; Makoto Shibuya; Sawako Maeno; Tadahiro Takada; Tomoaki Eguchi
Journal:  J Gastrointest Surg       Date:  2010-02       Impact factor: 3.452

6.  Prostaglandin E1 (PGE1) attenuates vasoconstriction induced by PGE2, PGD2 and phorbol myristate acetate in the perfused rat liver.

Authors:  H Inaba; M Araki; T Numai; T Mizuguchi
Journal:  J Anesth       Date:  1993-01       Impact factor: 2.078

7.  Treatment of fulminant viral hepatic failure with prostaglandin E. A preliminary report.

Authors:  S B Sinclair; G A Levy
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

Review 8.  Hepatic circulation: potential for therapeutic intervention.

Authors:  F Ballet
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.